Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments
March 20 2009 - 11:35AM
PR Newswire (US)
LITTLE FALLS, N.J., March 20 /PRNewswire-FirstCall/ -- CANTEL
MEDICAL CORP. (NYSE:CMN) announced the promotion of Andrew A.
Krakauer, President of the Company, to President and Chief
Executive Officer. Mr. Krakauer will also become a member of the
Board of Directors. Since joining Cantel in September 2004, Mr.
Krakauer served as Executive Vice President and COO, and since
April 2008 as President. The Board concurrently appointed Seth R.
Segel, Senior Vice President - Strategy and Corporate Development,
to the position of Executive Vice President and Craig A. Sheldon,
Senior Vice President - CFO, to the position of Senior Vice
President - CFO and Treasurer. In addition, Board member George
Fotiades was named Vice Chairman, replacing Alan Hirschfield, who
retired from such position on March 18th but remains an active
Board member. Mr. Fotiades, who joined the Board in May 2008, will
also become a member of the Office of the Chairman, joining Charles
M. Diker, Chairman of the Board, along with Messrs. Krakauer and
Segel. The new appointments became effective on March 18, 2009.
"Andy is precisely the right leader for Cantel," stated Diker.
"Since his appointment to President, Andy has provided decisive
leadership and strategic direction. Moreover, the Company's
performance has been exceptional since Andy took the helm."
Krakauer said, "I am honored by the Board's confidence in me. I
look forward to the continued implementation of our strategic plans
for continued growth and global expansion in infection prevention
and control markets. I am also very privileged to be working with
Cantel's phenomenal group of executives and our entire team of
loyal and hardworking employees." About Cantel Medical Corp. Cantel
Medical Corp. is a leading provider of infection prevention and
control products in the healthcare market. Our products include
specialized medical device reprocessing systems for renal dialysis
and endoscopy, dialysate concentrates and other dialysis supplies,
disposable infection control products primarily for the dental
industry, water purification equipment, sterilants, disinfectants
and cleaners, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens. For further information, visit the Cantel website at
http://www.cantelmedical.com/. This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve
a number of risks and uncertainties, including, without limitation,
the risks detailed in Cantel's filings and reports with the
Securities and Exchange Commission. Such forward-looking statements
are only predictions, and actual events or results may differ
materially from those projected or anticipated. DATASOURCE: Cantel
Medical Corp. CONTACT: Andrew A. Krakauer, President and CEO of
Cantel Medical Corp., +1-973-890-7220; or Richard E. Moyer of
Cameron Associates, Inc., for Cantel Medical Corp.,
+1-212-554-5466, Web Site: http://www.cantelmedical.com/
Copyright
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Sep 2023 to Sep 2024